Viral hepatitis

Rafael Amaro, Eugene R. Schiff

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

Viral hepatitis constitutes the most common entity seen in hepatology practice. Hepatitis A vaccination is recommended for patients with chronic hepatitis. Both lamivudine and interferon are established therapies against chronic hepatitis B, with other treatments not equally effective. Adefovir dipivoxil is a promising new treatment for lamivudine-resistant hepatitis B mutants. Lamivudine and hepatitis B immunoglobulin are effective in preventing recurrence of hepatitis B after transplantation. The combination of interferon and ribavirin has been shown to be effective for treatment of hepatitis C. Studies support the antiviral, antifibrotic, and antineoplastic effect of interferon therapy. Recurrence of hepatitis C after transplantation has been associated with more rapid progression to cirrhosis. Other major advances in the field of viral hepatitis during the past year are highlighted.

Original languageEnglish (US)
Pages (from-to)262-267
Number of pages6
JournalCurrent opinion in gastroenterology
Volume17
Issue number3
DOIs
StatePublished - May 5 2001

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Viral hepatitis'. Together they form a unique fingerprint.

  • Cite this